Vermilion Therapeutics Inc.
About Vermilion Therapeutics Inc.
The startup develops targeted therapeutics for neurological disorders, cancer, and infectious diseases, focusing on conditions such as dementia, peripheral amyloidosis, and Alzheimer's. By utilizing specific drug formulations, the company aims to provide effective treatment options that improve patient outcomes in these critical health areas.
What does Vermilion Therapeutics Inc. do?
The startup develops targeted therapeutics for neurological disorders, cancer, and infectious diseases, focusing on conditions such as dementia, peripheral amyloidosis, and Alzheimer's. By utilizing specific drug formulations, the company aims to provide effective treatment options that improve patient outcomes in these critical health areas.
Where is Vermilion Therapeutics Inc. located?
Vermilion Therapeutics Inc. is based in Tokyo, Japan.
When was Vermilion Therapeutics Inc. founded?
Vermilion Therapeutics Inc. was founded in 2019.
How much funding has Vermilion Therapeutics Inc. raised?
Vermilion Therapeutics Inc. has raised 2280000.
- Location
- Tokyo, Japan
- Founded
- 2019
- Funding
- 2280000
- Employees
- 1 employees
- Major Investors
- Mitsubishi UFJ Capital